Place the nursing actions in order for a client who develops fever, hypotension, and hypoxia after CAR-T-cell therapy.
Ordered Response
Choose your responses, then check the answer.
Explanation
Immediate stabilization and toxicity recognition come first, followed by oncology escalation and concurrent infection evaluation, protocol-directed tocilizumab and supportive care, response reassessment, and further escalation when needed.
Quick answer Treat the pattern as possible cytokine release syndrome while evaluating infection and neurotoxicity.
Why this is correct CAR-T labels warn that CRS can be life-threatening and that neurologic toxicity may occur before, during, or after CRS. Severe or life-threatening CRS is treated with tocilizumab, sometimes with corticosteroids, plus supportive care.
Easy analogy or mental picture Calm the cytokine storm while checking whether infection or a neurologic storm is traveling with it.
Memory hook After CAR-T: fever plus pressure or oxygen change means CRS pathway now.
NCLEX decision rule Sequence stabilization, grading, treatment, and repeated evaluation; do not let one diagnosis suppress assessment for infection or ICANS.
Why the other choices are wrong Waiting for spontaneous resolution, skipping neurologic checks, or giving therapy without hemodynamic support can miss rapid deterioration.
References
1FDA: CARVYKTI Prescribing InformationCRS and ICANS recognition, monitoring, supportive care, and tocilizumab treatment for severe or life-threatening CRS
CAR-T toxicity sequenceTrack fever, oxygen, pressure, perfusion, infection studies, CRS grade, mental status, handwriting or language change, treatment time, and response.